Recent News

• 07.18.2025 - ABVC BioPharma Records $100,000 Licensing Milestone From ForSeeCon, Strengthening Eye Health Program
• 06.26.2025 - ABVC BioPharma CEO Dr. Uttam Patil Recognized Among Elite Indian-Origin CEOs Making Global Impact in Science and Technology
• 06.05.2025 - Integrating Botanical Drugs into Western Medicine
• 06.03.2025 - ABVC BioPharma Announces Board Approval of Share Dividend Showing Confidence in Subsidiary Growth and Long-Term Shareholder Value

Recent Filings

• 07.18.2025 - 8-K/A Current report
• 07.15.2025 - SCHEDULE 13D/A General Statement of Acquisition of Beneficial Ownership
• 06.27.2025 - S-8 Securities to be offered to employees in employee benefit plans
• 06.04.2025 - 8-K Current report
• 06.03.2025 - SCHEDULE 13D General Statement of Acquisition of Beneficial Ownership
• 05.30.2025 - 8-K/A Current report
• 05.27.2025 - POS AM Post-Effective amendments for registration statement
• 05.27.2025 - POS AM Post-Effective amendments for registration statement
• 05.27.2025 - POS AM Post-Effective amendments for registration statement
• 05.22.2025 - S-3 Registration statement under Securities Act of 1933